You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CLL

Showing 1 - 25 of 1,319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

Not yet recruiting
  • CLL/SLL
  • Orelabrutinib and BG
  • Wuhan, Hubei, China
  • +1 more
Jun 15, 2023

Orelabrutinib in the Treatment of CLL/SLL

Not yet recruiting
  • CLL/SLL
    • (no location specified)
    Jul 26, 2023

    Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Questionnaires
    • Fit Bit
    • Houston, Texas
      M D Anderson Cancer Center
    May 18, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Ibrutinib 420 mg)

    Not yet recruiting
    • Autoimmune Hemolytic Anemia
    • +3 more
    • Ibrutinib 420 mg
    • (no location specified)
    Jan 12, 2023

    Unfit CLL Included in GIMEMA LLC1114 Trial Who Discontinued

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Observation
    • (no location specified)
    Oct 12, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    AML, Adult Trial in Hangzhou (CLL1 CAR-NK cell injection)

    Recruiting
    • AML, Adult
    • CLL1 CAR-NK cell injection
    • Hangzhou, Zhejiang, China
      Clinical research ethics committee of the first affiliated hospi
    Aug 30, 2023

    CLL, SLL Trial in Boston (Ofatumumab, High-Dose Methylprednisolone, Alemtuzumab)

    Terminated
    Has Results
    • CLL
    • SLL
    • Boston, Massachusetts
    • +1 more
    Jan 30, 2023

    Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL1 and CD38 dual-target CAR-T injection
    • Kunming, Yunnan, China
      920th Hospital of Joint LogisticsSupport Force of People's Liber
    Oct 26, 2023

    Study of the Metabolism in the Lymphatic Niche of CLL

    Recruiting
    • CLL
    • NO intervention
    • Nice, France
      Nice University Hospital
    Nov 2, 2022

    Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CLL1/+CD33 CAR-T
    • Fuzhou, Fujian, China
      Fujian Provincial Children's Hospital
    Jul 10, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Zhengzhou, Nanjing (TQB3909 tablet)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • TQB3909 tablet
    • Zhengzhou, Henan, China
    • +1 more
    Jul 17, 2023

    Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Victoria (5:2 Method (intermittent fasting

    Enrolling by invitation
    • Chronic Lymphocytic Leukemia (CLL)
    • Small Lymphocytic Lymphoma (SLL)
    • 5:2 Method (intermittent fasting regimen)
    • 16/8 Method (intermittent fast regimen)
    • Victoria, British Columbia, Canada
      Eleah Stringer
    Feb 2, 2023

    Leukemia, Chronic Lymphatic Trial in Stuttgart, Tuebingen (Peptide Vaccine, Imiquimod)

    Completed
    • Leukemia, Chronic Lymphatic
    • Stuttgart, Baden-Wuerttemberg, Germany
    • +4 more
    Nov 24, 2022

    Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Granada, Spain
      • +4 more
      Nov 8, 2023

      Chronic Lymphocytic Leukemia Trial in Russian Federation

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Irkutsk, Russian Federation
        • +5 more
        Jan 17, 2023

        Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

        Recruiting
        • Relapsed or Refractory CD19+ B-cell Lymphoma
        • +2 more
        • TBI-2001
        • +2 more
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jul 26, 2023

        Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)

        Active, not recruiting
        • Chronic Lymphocytic Leucemia
        • Cologne, Germany
          German CLL Study Group
        Sep 14, 2022

        CLL/SLL Trial in Worldwide (Epcoritamab, Venetoclax)

        Not yet recruiting
        • CLL/SLL
        • Antwerpen, Belgium
        • +23 more
        Mar 28, 2023

        Malignant Tumors Stated as Primary Lymphoid Haematopoietic, Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in

        Active, not recruiting
        • Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic
        • +2 more
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Jan 20, 2023

        Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

        Not yet recruiting
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • +5 more
        • (no location specified)
        Jul 21, 2023

        CLL/SLL Trial in Beijing (orelabrutinib)

        Recruiting
        • CLL/SLL
        • Beijing, Beijing, China
        • +1 more
        Aug 5, 2022

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Dec 5, 2022